期刊文献+

腹膜假黏液瘤的研究进展 被引量:1

Research progress on pseudomyxoma peritonei
原文传递
导出
摘要 腹膜假黏液瘤是临床上较为少见的一类疾病,主要特征为黏液外分泌性细胞在腹膜或网膜种植而导致大量胶冻黏稠样腹腔积液。临床上无明显特异性表现,误诊率较高。通过提高对腹膜假黏液瘤的认识、完善相关检查和合理的标本取材进行病理检查可以提高腹膜假黏液瘤的诊断率。采用肿瘤细胞减灭术或大部肿瘤切除手术的手术方法联合腹腔热灌注化疗,有助于提高患者的生存期。 Pseudomyxoma peritonei is a rare kind of clinical disease, mainly characterized by mucus exocrine cells grown in the peritoneum or omentum sticky which caused lots of jelly-like ascites. There is no obvious clinical specificity performance for pseudomyxoma peritonei, which is always misdiagnosed. By enhancing the awareness of pseudomyxoma peritonei, improving the relevant checks and reasonably extracting specimens for pathological exami-nation can improve diagnosing rate of pseudomyxoma peritonei. Using complete cytoreductive surgery or major debulking surgery combined with intraperitoneal hyperthermic perfusion chemotherapy help to improve the survival of patients with pseudomyxoma peritonei.
出处 《国际外科学杂志》 2013年第7期468-471,共4页 International Journal of Surgery
基金 广东省科技计划项目(No.20098060700019) 广州市卫生局重点项目(No.201102A212018)
关键词 阑尾肿瘤 腹膜假黏液瘤 诊断 化疗 黏液瘤 Appendiceal neoplasms Pseudomyxoma peritonei Diagnosis Chemotherapy Myxoma
  • 相关文献

参考文献3

二级参考文献29

  • 1李基业,李涛,邓群,张鑫奎.腹腔镜下活检术诊断腹膜假性黏膜瘤九例[J].中华消化内镜杂志,2005,22(3):205-206. 被引量:1
  • 2Bernardino Rampone,Franco Roviello,Daniele Marrelli,Enrico Pinto.Giant appendiceal mucocele: Report of a case and brief review[J].World Journal of Gastroenterology,2005,11(30):4761-4763. 被引量:25
  • 3徐向阳,熊枝繁,曹仕琼,黄德珍,刘祥,吴燕茹.腹膜假粘液瘤的CT表现与病理基础[J].放射学实践,2005,20(12):1050-1052. 被引量:7
  • 4吕勇刚,曹大勇,陶开山,王岭.腹膜假性粘液瘤诊治体会(附12例报告及文献复习)[J].现代肿瘤医学,2006,14(9):1133-1135. 被引量:5
  • 5Smeenk RM, van Velthuysen ML, Verwaal VJ, et al. Appen- diceal neoplasms and pseudomyxoma peritonei: a population based study. Eur J SurgOneol, 2008,34(2):196-201.
  • 6Ronnett BM, Zahn CM, Kurman RJ, et al, Disseminated perito neal adenomucinosis and peritoneal mutinous carcinomatosis. A clinicopathologic analysis of 109 cases with emphasis on dist in- guishing pathologic features, site of origin, prognosis, and rela tionship to "pseudomyxoma peritonei". Am J Surg Pathol, 1995, 19(12) :1390-1408.
  • 7Glehen O, Kwiatkowski F, Sugarbaker PH, et al. Cytoreductive surgery combined with perioperative intraperitoneal chemothera py for the management of peritoneal careinomatosis from colorec tal cancer: a multi-institutional study. J Clin Oncol, 2004, 22(16):3284-3292.
  • 8Krause J, Bergman A, Graf W, et al. Ultrasonography findings and tumour quantification in patients with pseudomyxoma perito nei. Eur J Radiol, 2011. [gpub ahead of print].
  • 9Bradley RF, Stewart JH, Russell GB, et al. Pseudomyxoma per itonei of appendiceal origin: a clinieopathologic analysis of 101 pa tients uniformly trated at a single institution, with leiterature re view. Am J Surg Pathol, 2OO6,30(5):551-559.
  • 10Baratti D, Kusamura S, Martinetti A, etal. Prognostic value of circulating tumor markers in patients with pseudomyxoma perito nei treated with cytoreductive surgery and hyperthermic intraper itoneal chemotherapy. Ann Surg Oncol, 2007,14(8):2300-2308.

共引文献55

同被引文献11

  • 1Wang H, Wang X J, Ju YF, et al. Clinicopathological features and prognosis of pseudomyxoma peritonei [ J]. Exp Ther Med, 2014, 7 (1): 185-190.
  • 2Smeenk RM, van Vehhuysen ML, Verwaal VJ, et al. Appendiceal neoplasms and pseudomyxoma peritonei: a population based study [J]. EurJSurgOncol, 2008, 34(2): 196 -201.
  • 3Bosman FT, Cameiro F, Hrnban RH, et al. World Heahh Organiza- tion classification of turnouts of the digestive system[ M ]. Lyon : IARC Press, 2010.
  • 4Bevan KE, Mohamed F, Moran BJ. Pseudomyxoma peritonei[ J]. World J Gastrointest Oncol, 2010, 2( 1 ) :44 -50.
  • 5Miner TJ, Shia J, Jaques DP, et al. Longterm survlval folio'sing treat- ment of pseudomyxoma peritonei: an analysis of surgical therapy[ J]. Ann Surg, 2005, 241(2) : 300 -308.
  • 6Amini A, Masoumi - Moghaddam S, Ehteda A, et al. Secreted mucins in pseudomyxoma peritonei: pathophysiological significance and poten- tial therapeutic prospects [ J ]. Orphanet J Rare Dis, 2014, 9:71 - 82.
  • 7Carmignani CP, Hampton R, Sugarbaker CE, et al. Utility of CEA and CA 19 - 9 tumor markers in diagnosis and prognostic assessment of mucinous epithelial cancers of the appendix [ J ]. J Surg Oncol, 2004, 87(4) :162 - 166.
  • 8Koh JL, Liauw W, Chua J, et al. Carbohydrate antigen 19 -9 (CA 19 -9) is an independent prognostic indicator in pseudomyxoma per- itonei post cytoreductive surgery and perioperative intraperitoneal chemotherapy[J]. Gastrointest Oncol, 2013, 4(2) : 173 - 181.
  • 9唐鸿生,崔书中,巴明臣.腹膜假性黏液瘤的临床综合诊治现状[J].中华外科杂志,2010,48(7):550-552. 被引量:3
  • 10李艳青,胡君,温宏武.腹膜假黏液瘤诊治的研究进展[J].中华妇产科杂志,2014,49(1):70-72. 被引量:3

引证文献1

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部